Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiparity in women with multiple sclerosis causes less long-term disability: Yes.
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.
Factors Related to Social Support in Neurological and Mental Disorders.
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Commentary on: "Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss", by G. R. W. Moore, et al. in J Neurol (2008) 255: DOI 10.1007/s00415-008-0002-z.
White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study.
Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No.]
Interventions for children coping with parental multiple sclerosis: A systematic review.
Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases.
Motor network efficiency and disability in multiple sclerosis.
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Ginsenoside Rb1 attenuates activated microglia-induced neuronal damage.
Optimization of Magnetization-Prepared 3-Dimensional Fluid Attenuated Inversion Recovery Imaging for Lesion Detection at 7 T.
Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.
3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
[Immunoregulative effect of Fasudil on encephalomyelitic T cells in experimental autoimmune encephalomyelitis mice].
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
[Reflections on the outcome measures in the clinical trials of multiple sclerosis].
Pages
« first
‹ previous
…
606
607
608
609
610
611
612
613
614
…
next ›
last »